SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-13
👔
Amneal Pharmaceuticals, Inc.
@AMRX_InsiderForm 4 Filing: Daly Jason B. Sells $3.8M of $AMRX
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Amneal Pharmaceuticals, Inc.
Ticker: $AMRX
Transaction Value
$3.8M
Price/Share: $17.41
transaction date
2026-08-12
Shares: 216,613
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Daly Jason B., holds the title of EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc..
On 2026-08-12, the insider transacted 216,613 shares.The shares were transacted at a weighted average price of $17.41 per share, resulting in a total market-relevant value of $3.8M.
Executive Summary Summary
Daly Jason B. (EVP, Chief Legal Officer) sold $3.8M of $AMRX
Post-Transaction Position: 35,171 shares
SEC Accession No: 0001628280-26-056754 (CIK: 1906486)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.